SpringWorks Therapeutics Inc (SWTX) — Capital Reinvestment Ratio
SpringWorks Therapeutics Inc (SWTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($15.07 Million) in capital expenditures ($54.00K). See SpringWorks Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SpringWorks Therapeutics Inc Capital Reinvestment Ratio (2004–2010)
This chart tracks SpringWorks Therapeutics Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for SpringWorks Therapeutics Inc (2004–2010)
Year-by-year Capital Reinvestment Ratio for SpringWorks Therapeutics Inc from 2004 to 2010. For live market cap and broader valuation context, see SpringWorks Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.34x | $5.61 Million | $1.89 Million | ▲ +2.1% |
| 2009 | 0.33x | $5.23 Million | $1.73 Million | ▲ +274.2% |
| 2008 | 0.09x | $7.10 Million | $626.00K | ▼ -29.3% |
| 2007 | 0.12x | $5.70 Million | $710.00K | ▼ -92.2% |
| 2006 | 1.59x | $748.00K | $1.19 Million | ▲ +733.4% |
| 2005 | 0.19x | $4.01 Million | $766.00K | ▲ +91.7% |
| 2004 | 0.10x | $3.83 Million | $382.00K | — |